Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Cancer. 2018 Apr 23;124(11):2390–2398. doi: 10.1002/cncr.31271

Table 2.

Additional Summary Statistics

Up-to-date
with colorectal
cancer
screening
P Up-to-date
with breast
cancer
screening
P

Females [N=262,242]
  Ever had false-positive breast cancer screening
    No 62.1% <0.001 88.5% <0.001
      Repeat breast imaging within 91 d (no biopsy) 68.8% 95.0%
      Breast biopsy 71.0% 96.2%
  Ever had false-positive colorectal cancer screening
    No 90.1% 0.75
    Positive FOBT (negative follow-up colonoscopy within 6 m, without biopsy/polypectomy)* 90.3%
Males [N=188,242]
  Ever had false-positive prostate cancer screening
    No 62.7% <0.001 -
      PSA ≥4.0 ng/mL (repeated within 91 d, no imaging/biopsy) 70.4%
      Prostate imaging/biopsy 75.9%
*

We did not consider false-positives for patients who underwent initial colonoscopy because repeat screening would not be expected during the study period.

Repeat screening after a false-positive would not be expected during the study period.